Koji Yanagi

548 total citations
19 papers, 422 citations indexed

About

Koji Yanagi is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Koji Yanagi has authored 19 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Koji Yanagi's work include Lipoproteins and Cardiovascular Health (9 papers), Cardiovascular Disease and Adiposity (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). Koji Yanagi is often cited by papers focused on Lipoproteins and Cardiovascular Health (9 papers), Cardiovascular Disease and Adiposity (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). Koji Yanagi collaborates with scholars based in Japan, Brazil and United States. Koji Yanagi's co-authors include Mariko Harada‐Shiba, Shinji Kihara, Shuichi Nozaki, Kaoru Kameda-Takemura, Yūji Matsuzawa, Shizuya Yamashita, Masato Ishigami, Ken‐ichi Hirano, Naohiko Sakai and Masakazu Menju and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Arteriosclerosis Thrombosis and Vascular Biology and Atherosclerosis.

In The Last Decade

Koji Yanagi

19 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Koji Yanagi Japan 10 316 177 107 99 51 19 422
Curtis Rambaran United Kingdom 9 271 0.9× 101 0.6× 182 1.7× 67 0.7× 58 1.1× 19 462
Claudia Morozzi Italy 12 235 0.7× 77 0.4× 117 1.1× 54 0.5× 32 0.6× 19 332
Federico Bigazzi Italy 12 256 0.8× 90 0.5× 150 1.4× 63 0.6× 105 2.1× 47 462
M. Ciccarese Italy 10 266 0.8× 250 1.4× 115 1.1× 57 0.6× 106 2.1× 16 589
Raimundo de Andrés Spain 11 219 0.7× 76 0.4× 142 1.3× 76 0.8× 54 1.1× 19 415
Nicholas Colyvas United States 4 201 0.6× 160 0.9× 132 1.2× 80 0.8× 52 1.0× 7 345
Jacy R. Crosby United States 4 234 0.7× 212 1.2× 91 0.9× 77 0.8× 76 1.5× 6 465
Hendrik du Toit Theron United States 5 517 1.6× 222 1.3× 229 2.1× 171 1.7× 53 1.0× 6 597
Robert A. Hegele Canada 5 509 1.6× 241 1.4× 158 1.5× 199 2.0× 83 1.6× 5 641
Anders Berg Wulff Denmark 8 291 0.9× 247 1.4× 160 1.5× 82 0.8× 29 0.6× 20 438

Countries citing papers authored by Koji Yanagi

Since Specialization
Citations

This map shows the geographic impact of Koji Yanagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koji Yanagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koji Yanagi more than expected).

Fields of papers citing papers by Koji Yanagi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koji Yanagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koji Yanagi. The network helps show where Koji Yanagi may publish in the future.

Co-authorship network of co-authors of Koji Yanagi

This figure shows the co-authorship network connecting the top 25 collaborators of Koji Yanagi. A scholar is included among the top collaborators of Koji Yanagi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koji Yanagi. Koji Yanagi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Yamashita, Shizuya, Hidenori Arai, Hideaki Bujo, et al.. (2020). Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Coronary Heart Disease (PROSPECTIVE). Journal of Atherosclerosis and Thrombosis. 28(2). 103–123. 28 indexed citations
2.
Nohara, Atsushi, Koji Yanagi, Masayuki Yoshida, et al.. (2018). Safety and Efficacy of Lomitapide in Japanese Patients with Homozygous Familial Hypercholesterolemia (HoFH): Results from the AEGR-733-301 Long-Term Extension Study. Journal of Atherosclerosis and Thrombosis. 26(4). 368–377. 31 indexed citations
3.
Maruyama, Chizuko, Katsunori Ikewaki, Atsushi Nohara, et al.. (2018). Dietary Intake during 56 Weeks of a Low-Fat Diet for Lomitapide Treatment in Japanese Patients with Homozygous Familial Hypercholesterolemia. Journal of Atherosclerosis and Thrombosis. 26(1). 72–83. 4 indexed citations
4.
Ogura, Masatsune, Mika Hori, Koji Y. Arai, et al.. (2017). Achilles Tendon Ultrasonography for Diagnosis of Familial Hypercholesterolemia Among Japanese Subjects. Circulation Journal. 81(12). 1879–1885. 34 indexed citations
5.
Harada‐Shiba, Mariko, Katsunori Ikewaki, Atsushi Nohara, et al.. (2017). Efficacy and Safety of Lomitapide in Japanese Patients with Homozygous Familial Hypercholesterolemia. Journal of Atherosclerosis and Thrombosis. 24(4). 402–411. 36 indexed citations
6.
Masuda, Daisaku, Takuya Kobayashi, Hiroyuki Hanada, et al.. (2017). Effects of a Dipeptidyl Peptidase 4 Inhibitor Sitagliptin on Glycemic Control and Lipoprotein Metabolism in Patients with Type 2 Diabetes Mellitus (GLORIA Trial). Journal of Atherosclerosis and Thrombosis. 25(6). 512–520. 21 indexed citations
7.
Yanagi, Koji, et al.. (2015). Treatment of Ureterosciatic Hernia with a Ureteral Stent. Case Reports in Nephrology and Dialysis. 5(1). 83–86. 8 indexed citations
8.
Kishida, Ken, Yasuhiko Nakagawa, Hironori Kobayashi, et al.. (2014). Increased serum C1q-binding adiponectin complex to total-adiponectin ratio in men with multi-vessel coronary disease. Diabetology & Metabolic Syndrome. 6(1). 64–64. 2 indexed citations
9.
Kishida, Ken, Yasuhiko Nakagawa, Hironori Kobayashi, et al.. (2014). High serum C1q-binding adiponectin levels in male patients with acute coronary syndrome. Cardiovascular Diabetology. 13(1). 9–9. 13 indexed citations
10.
Hori, Mika, Mitsuaki Ishihara, Hisashi Makino, et al.. (2014). Removal of Plasma Mature and Furin-Cleaved Proprotein Convertase Subtilisin/Kexin 9 by Low-Density Lipoprotein-Apheresis in Familial Hypercholesterolemia: Development and Application of a New Assay for PCSK9. The Journal of Clinical Endocrinology & Metabolism. 100(1). E41–E49. 47 indexed citations
11.
Kishida, Ken, Yasuhiko Nakagawa, Koji Yanagi, et al.. (2012). Metabolic syndrome correlates intracoronary stenosis detected by multislice computed tomography in male subjects with sleep-disordered breathing. Diabetology & Metabolic Syndrome. 4(1). 6–6. 4 indexed citations
12.
Nakagawa, Yasuhiko, Ken Kishida, Tohru Funahashi, Koji Yanagi, & Iichiro Shimomura. (2012). Coexistence of Visceral Fat Accumulation and Sleep-Disordered Breathing Correlates with Coronary Artery Disease. Journal of Atherosclerosis and Thrombosis. 19(8). 728–735. 5 indexed citations
13.
Isoyama, Tadahiro, et al.. (2004). Retroperitoneal laparoscopic heminephrectomy for a horseshoe kidney. 17(1). 105–107. 1 indexed citations
14.
Mori, Masahide, et al.. (2004). [A case of non-small cell lung carcinoma successfully treated with carboplatin and weekly paclitaxel under renal dysfunction].. PubMed. 31(12). 2061–4. 4 indexed citations
15.
Yanagi, Koji. (2002). Effects of Nitric Oxide on Bladder Outlet Obstruction in Rats. Yonago acta medica. 45(1). 19–26. 2 indexed citations
16.
Yanagi, Koji, et al.. (2000). EXTRAGONADAL GERM CELL TUMOR COEXISTED WITH RENAL CELL CARCINOMA. The Japanese Journal of Urology. 91(9). 637–640. 1 indexed citations
17.
Yanagi, Koji, Shizuya Yamashita, Hisatoyo Hiraoka, et al.. (1997). Increased serum remnant lipoproteins in patients with apolipoprotein E7 (apo ESuita). Atherosclerosis. 131(1). 49–58. 16 indexed citations
18.
19.
Hirano, Ken‐ichi, Shizuya Yamashita, Yoshio Kuga, et al.. (1995). Atherosclerotic Disease in Marked Hyperalphalipoproteinemia. Arteriosclerosis Thrombosis and Vascular Biology. 15(11). 1849–1856. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Curtis Rambaran Breakdown of academic impact, for papers by Claudia Morozzi Breakdown of academic impact, for papers by Federico Bigazzi Breakdown of academic impact, for papers by M. Ciccarese Breakdown of academic impact, for papers by Raimundo de Andrés Breakdown of academic impact, for papers by Nicholas Colyvas Breakdown of academic impact, for papers by Jacy R. Crosby Breakdown of academic impact, for papers by Hendrik du Toit Theron Breakdown of academic impact, for papers by Robert A. Hegele Breakdown of academic impact, for papers by Anders Berg Wulff
Rankless by CCL
2026